1. GBp


    Today's change

    9.50 / +0.66%

    1 year change


    As of May 25 2016 17:11 BST. Data delayed by at least 15 minutes.

Search for GlaxoSmithKline PLC and
  1. May 19, 2016

    Pull together to prevent a superbug apocalypse

    Jim O’Neill, UK Treasury minister and former Goldman Sachs economist, has focused the world’s attention on...

  2. Fast FT

    May 17, 2016

    Epstein out as Novartis splits cancer from pharma unit

    Swiss pharmaceuticals group Novartis announced on Tuesday plans to separate its oncology unit from its pharmaceuticals...

Special Reports

  1. The Connected Business

    Cloud computing is still in its infancy. Most big companies are assessing how far to g...
  2. FT Health: Vaccines

    In today’s connected world, where outbreaks of infectious disease can spread faster th...
Search more Special Reports on this topic.

  1. May 10, 2016

    Progress on maternal mortality hindered by ‘funding mismatch’

    When thousands of delegates travel to the latest Women Deliver conference in Copenhagen this month, they will see both...

  2. May 3, 2016

    Witty looks to cement his legacy as GSK’s performance improves

    Sir Andrew Witty’s final 11 months in charge of GlaxoSmithKline will not be the victory lap he might have hoped for...

  3. April 29, 2016

    GlaxoSmithKline’s mouthwash to be life saver for babies

    A brand of mouthwash has been reformulated by GlaxoSmithKline into an antiseptic gel that could save hundreds of...

  4. April 27, 2016

    GSK chief says pressure on US drug prices to rise

    Pressure on drug prices in the US will continue to grow regardless of who wins November’s presidential election, the...

  5. April 27, 2016

    Sir Andrew Witty fuels GSK turnround hopes with results boost

    Sir Andrew Witty began his final year in charge of GlaxoSmithKline with a stronger than expected rise in first-quarter...

  6. Fast FT

    April 27, 2016

    GlaxoSmithKline Q1 growth aided by HIV drugs

    Sir Andrew Witty began his final year in charge of GlaxoSmithKline with a stronger-than-expected rise in first quarter...

  7. April 25, 2016

    Drug prices: Tweaking the formula

    What is the value of a human life? It is one of the most fraught questions in public policy as governments around the...

  8. April 25, 2016

    Vaccine development needs global alliance

    Who has saved the most lives in human history? Claims can be made for various scientific pioneers and political...

  9. April 25, 2016

    Vaccines are among big pharma’s best-selling products

    Ask people to name Pfizer’s best-selling product and many would opt for one of its most famous drugs: Viagra, for...

  10. April 24, 2016

    WHO stays positive as dose of reality hits malaria vaccine hopes

    It should be a time for optimism among those engaged in the fight against malaria. Incidence of the disease fell 37 per...

  11. April 19, 2016

    The secret of a world-class biotech sector

    Britain, it is often said, has world-class science but too few world-class science-based companies. Nowhere is this...

  12. April 3, 2016

    GSK returns to battle against cancer

    When GlaxoSmithKline agreed to sell its oncology drugs to Novartis for $16bn in 2014, it looked like the UK...

  13. April 1, 2016

    GSK to allow staggered payments for EMA-approved gene therapy

    GlaxoSmithKline is to allow health systems to make staggered payments for one of Europe’s first gene therapies in a...

  14. March 31, 2016

    GSK to relax intellectual property and help developing world

    GlaxoSmithKline has promised not to seek patent protection on medicines in low-income countries as part of measures by...

  15. Fast FT

    March 31, 2016

    GSK to loosen IP protections in poorer countries

    GlaxoSmithKline has promised not to seek patent protection on medicines in low-income countries as part of a range of...

  16. Fast FT

    March 29, 2016

    British drugmakers receive drug approvals in Japan

    UK pharmaceuticals giants AstraZeneca and GlaxoSmithKline have both received some good news from Japanese regulators...

  17. March 17, 2016

    Lessons in succession from GSK and Rio

    If you’ve ever envied folks absorbed in puzzle magazines as you sit shuffling work papers on the train, here’s your...

  18. March 17, 2016

    Sir Andrew Witty’s tenure at GSK divides opinion

    Two views exist of Sir Andrew Witty. He could be seen as the visionary leader who restructured GlaxoSmithKline for...

  19. March 17, 2016

    GSK: wheel of fortune

    He played a bad hand well is an honourable epitaph for a private life. It will not do for the tenure of a public...

  20. Fast FT

    March 17, 2016

    Opening Quote: GSK/Rio Tinto bosses retiring; Budget sweeteners

    The bosses of GlaxoSmithKline and Rio Tinto are retiring, Ted Baker profits are climbing, there were some artificial...

  21. March 17, 2016

    Sir Andew Witty defends GSK strategy as plans to retire revealed

    Sir Andrew Witty has denied that his departure from GlaxoSmithKline will trigger a break-up of Britain’s biggest...

  22. FT Alphaville

    March 17, 2016

    FT Opening Quote

    The bosses of GlaxoSmithKline and Rio Tinto are retiring, Ted Baker profits are climbing, there were some artificial...

  23. Fast FT

    March 17, 2016

    Sir Andrew Witty to leave GlaxoSmithKline in 2017

    Sir Andrew Witty, the chief executive of GlaxoSmithKline, will step down from the UK drugmaker next year, the company...

  24. March 16, 2016

    Pharma merger to create UK champion in respiratory medicines

    A former senior executive at AstraZeneca is aiming to create a new UK champion in respiratory medicines after a £441m...

  25. March 8, 2016

    Bristol-Myers Squibb shakes up China operations to combat bribery

    Bristol-Myers Squibb has tightened rules on the way its sales representatives work with doctors in China after a $14m...

  26. March 2, 2016

    Overseas requests for SFO help in fraud cases increase

    Requests to the UK from overseas for help in fighting financial crime rose 62 per cent last year, highlighting the...

  27. March 2, 2016

    Scientists aim to harness power of body’s electrical impulses to treat patients

    Until now the pharmaceutical industry has been based on chemistry and biology. Patients are treated with drugs that...

  28. February 28, 2016

    GSK to start search for Andrew Witty’s successor

    GlaxoSmithKline is gearing up to begin a formal search for its next chief executive as Sir Andrew Witty’s eight-year...

  29. February 28, 2016

    ‘Ovaltine Index’ showcases a UK heritage

    Last week, the FT30 index of big, old British businesses was rejigged to include Burberry, maker of macs and beltbags....

  30. February 25, 2016

    HIV unit emerges as ‘critical’ driver of GSK growth

    It is only a year since GlaxoSmithKline was considering a spin-off of its HIV unit as a way to unlock value for...

  31. February 23, 2016

    Health spending cannot be set by fans of Facebook and Instagram

    To have the option of saving a child’s life and to reject it seems more than callous. It is the ugliest of affronts to...

  32. Fast FT

    February 16, 2016

    Merlin poaches new CFO from Dechra Pharmaceuticals

    Alton Towers and Legoland operator Merlin Entertainments has poached its new chief financial officer from a FTSE 250...

  33. February 15, 2016

    Incumbents, dark arts and the opposite of innovation

    A colleague recently minted a new word by accident — “incumbation”. It won’t catch on but its fleeting appearance made...

  34. February 12, 2016

    GSK fined £37m for stifling launch of rival drug Seroxat

    GlaxoSmithKline has been fined £37m for illegally stifling the launch of a cheap rival drug, marking the biggest...

  35. Fast FT

    February 12, 2016

    GlaxoSmithKline hit with £37m fine

    UK pharma company GlaxoSmithKline has been hit with a £37m fine by the Competition and Markets Authority for “illegal...

  36. February 8, 2016

    Sir Philip should beef up governance code to get women into top jobs

    “She is one of those managing females,” the head of a small company said recently and dismissively. Thankfully, he is...

  37. February 4, 2016

    Numbers games and existential angst

    Two down-at-heel figures loitered in a desolate landscape. It could have been Waiting for Godot, a play by Irish...

  38. Fast FT

    February 4, 2016

    Opening Quote: Shell protects divi, Compass ploughs on

    Shell’s profits have slumped with the oil price, AstraZeneca’s sales are stalling, the Bank of England is set to hold...

Search for GlaxoSmithKline PLC and


Videos from FT.com that closely match this topic

  1. Sir Andrew Witty’s strategy for returning GlaxoSmithKline to ...
    May 11, 2015

    Sir Andrew Witty’s strategy for returning GlaxoSmithKli...

  2. Today’s top headlines from the FirstFT briefing...
    February 4, 2015

    Today’s top headlines from the FirstFT briefing

  3. Pharmaceuticals group announces cost cutting...
    October 22, 2014

    Pharmaceuticals group announces cost cutting